Stay updated on Emapalumab Clinical Trial in MAS/sHLH
Sign up to get notified when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.

Latest updates to the Emapalumab Clinical Trial in MAS/sHLH page
- Check5 days agoChange DetectedThe page's revision information was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe change is limited to a revision tag update from v3.4.1 to v3.4.2, with no observed impact on the page content, layout, or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible page content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedIntroduces a new 'Show glossary' option and makes minor capitalization changes to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision/version updates from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the revision history. This update is an administrative change to the page's revision record and does not modify study content.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a dedicated Locations section including Ohio, updating where the study is conducted. Removed the HHS Vulnerability Disclosure footer link and updated the page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Emapalumab Clinical Trial in MAS/sHLH
Enter your email address, and we'll notify you when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.